Trial Profile
Effect of the HMG-CoA reductase inhibitor atorvastatin calcium, Lipitor, in the treatment of Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Acronyms ADCLT
- 15 Oct 2005 New trial record.